Illustration for: Physical AI's Biggest Week Yet: $21 Billion

Physical AI's Biggest Week Yet: $21 Billion

Six deals in seven days — Lumilens, Hadrian, Terafab, Valar Atomics, Base Power and K2 Space — pushed more than $21 billion into reactors, factories, satellites and chips, not a single model release among them.

By the Numbers

$21.37B
Combined week total
6 rounds
Deals counted
$16.8B (Terafab)
Largest single deal
Aug 3-8, 2026
Window
TC
By the AI Desk
Edited by Trace Cohen · Early-stage VC & angel · Founder, New York Venture Partners
3 min read
ShareXLinkedInEmail

THE RUNDOWN

1

Six rounds — Lumilens ($700M+), Hadrian ($1.37B), Terafab ($16.8B), Valar Atomics ($1B), Base Power ($1B) and K2 Space ($500M) — closed within a single week, totaling roughly $21.37B

2

None of the six went to a foundation-model lab: the money split across optical interconnects, precision manufacturing, chip fabrication, nuclear reactors, grid batteries and satellites

3

Terafab's $16.8B alone accounts for nearly 80% of the week's total, and Tesla and SpaceX are funding it directly rather than through a typical venture round

4

SpaceX's own Q2 capex of $18.4B — almost matching the entire week's infrastructure haul in a single company's quarterly spend — is the clearest sign of how much capital this buildout actually requires to sustain itself

TC

The VC Read · Trace's Take

Trace Cohen

The diligence item that matters more than any single valuation: ask what fraction of this capital is committed-but-undrawn versus actually spent, since Terafab's $16.8B and Hadrian's 5x step-up are both multi-year commitments, not checks cut this week. Compare against SpaceX's own $18.4B in ONE quarter of capex before assuming a week like this is unusual — at the pace hyperscalers and their orbit are spending, $21B a week may be the new baseline, not a spike.

Analysis

Six Deals, Seven Days, $21 Billion

Between August 3 and August 8, six separate US-linked infrastructure rounds put more than $21 billion of new capital into the physical layer underneath AI — reactors, chip fabs, satellites, factory automation and interconnects — and not one dollar of it went to a foundation-model lab. Lumilens emerged from two years of stealth with over $700 million in Series C funding at a $5.51 billion valuation to build the optical interconnects that link GPUs inside AI data centers, according to SiliconANGLE. Hadrian raised $1.37 billion at a $7.87 billion valuation — roughly five times its prior mark — to automate precision manufacturing for the defense-industrial base, per Bloomberg. And Tesla and SpaceX jointly committed $16.8 billion to Terafab, an initial-phase chip factory in Grimes County, Texas, according to TechCrunch — alone accounting for nearly 80% of the week's total.

The Rest of the Ledger

Add Valar Atomics' $1 billion Series B at a $6 billion valuation for small nuclear reactors, Base Power's $1 billion Series D at a $13 billion valuation for grid-scale home batteries, and K2 Space's $500 million Series D at a $6.8 billion valuation for high-power satellites, and the six-deal total comes to roughly $21.37 billion — more capital than most entire quarters of foundation-model funding this year, concentrated into a single week.

Why the Money Is Moving Down the Stack

The pattern isn't new — Pulse has tracked model-layer headlines competing with infrastructure capital all year — but the concentration is. A reactor, a chip fab, a satellite constellation and a battery factory all share one property a foundation model doesn't: once built, the physical capacity is hard for a competitor to replicate quickly, and hard for a customer to walk away from once it's under contract. Lumilens' first product is already running in a hyperscaler's production data centers under a multi-year agreement. Hadrian supplies precision parts to SpaceX and Anduril. That kind of embedded, contracted demand is a different risk profile than betting on which lab ships the best model next quarter — which is part of why investors are willing to underwrite valuations this large on companies that, in Lumilens' case, spent two years in stealth before saying a word publicly.

The Numbers In Context

Hadrian's 5x valuation step-up in one round has few direct comps outside this specific cycle; Lumilens' $5.51 billion mark for a two-year-old company sits above rival optical-interconnect startup Celestial AI's roughly $3 billion 2025 valuation, but below what a public comp like Coherent or Broadcom's optics division would suggest on a revenue multiple, mostly because Lumilens hasn't disclosed how much of its multi-billion-dollar hyperscaler contract has actually been recognized as revenue yet. Terafab's $16.8 billion dwarfs everything else in the group, but it's a joint capital commitment from two already-public companies, not a venture valuation — a meaningfully different kind of bet than a Series B or Series D priced by outside investors betting on a return.

What Founders and GPs Should Take From This

For anyone underwriting AI-infrastructure exposure right now, the read isn't "physical AI is safer than model-layer AI" — it's that the diligence questions are different. A signed hyperscaler contract, a defense-primes supply relationship, or a joint capital commitment from an already-cash-generative parent company is a different kind of proof point than a benchmark score or a user-growth chart, and GPs pricing infrastructure deals should be asking for backlog-to-valuation ratios and contract concentration, not model-eval scores.

The Counterweight

SpaceX's own Q2 earnings are the cautionary data point sitting right next to this week's enthusiasm: the company spent $18.4 billion on capex in a single quarter — nearly matching this entire week's infrastructure haul — while revenue grew 92% to $7.81 billion, according to CNBC. That's the risk nobody underwriting this wave is pricing cleanly: capex commitments this large assume AI compute demand keeps compounding at its current rate for years, and reactors, fabs and satellite constellations take years to site, permit and build — meaning the bill comes due long before anyone can prove the demand was real rather than anticipatory. If growth decelerates even modestly, this week's $21 billion looks like foresight; if it doesn't, it looks like the first wave of a capacity glut nobody wanted to be the one holding.

The number worth tracking isn't next week's funding total — it's whether Lumilens' hyperscaler contract expands to a second customer, and whether Hadrian's defense-primes relationships convert into disclosed backlog, before the next round of infrastructure money gets priced on trajectory alone.

ShareXLinkedInEmail

Key Sources

2 sources

THE WIRE in your inbox— Tech, startup & VC news with Trace's take. Free, no spam.